Posture Correction in Cubital Tunnel Syndrome
Launched by YALE UNIVERSITY · Oct 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a device called the UpRight Go posture trainer can help reduce the symptoms of cubital tunnel syndrome in patients who have not had surgery for this condition. Cubital tunnel syndrome can cause pain, numbness, and weakness in the hand and fingers, particularly affecting the area controlled by the ulnar nerve. The trial aims to see if using the posture trainer can improve these symptoms, which will be measured through pain scores and other assessments.
To be eligible for this study, participants should be adults aged between 18 and 99 years who experience signs of cubital tunnel syndrome, such as pain or weakness in their hands. They should be able to commit to wearing the posture trainer daily and using a related smartphone app. However, individuals who have had certain surgeries or have specific health conditions, like pregnancy or diabetes-related nerve pain, may not be able to participate. If you join the study, you can expect to wear the posture trainer regularly and complete questionnaires about your symptoms, helping researchers understand how well this device works for managing cubital tunnel syndrome.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Provision of signed and dated informed consent form
- • Stated willingness to comply with all study procedures and availability for the duration of the study
- • Adult patients, between 18 and 99 years old
- • Exhibiting signs and symptoms consistent with cubital tunnel syndrome including but not limited to pain, numbness, or paresthesia in an ulnar distribution, loss of grip strength, or loss of fine motor control of the fingers.
- • Nerve conduction study, electromyography, MRI or ultrasound results consistent with the diagnosis of cubital tunnel syndrome
- • Ability to wear a posture trainer daily and manage the associated smartphone application and questionnaire
- Exclusion Criteria:
- • History of spinal surgery, hand surgery or hand/wrist fracture
- • History of cubital tunnel release surgery or carpal tunnel syndrome
- • Pregnancy or lactation
- • Known allergic reactions to silicon
- • Long-standing history of T2DM, documented neuropathic pain
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
New Haven, Connecticut, United States
Patients applied
Trial Officials
Elspeth Hill, MBChB, PhD, MRes, MRCS
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported